The Alliance for Clinical Trials in Oncology has recently launched several new clinical trials exploring targeted radiation therapy, improved treatment strategies and other innovative approaches to cancer care. From testing new radiation therapy techniques for lung cancer to treatments for breast cancer side effects, these trials aim to improve outcomes, reduce side effects, and deliver more…
The Alliance for Clinical Trials in Oncology is currently seeking nominations for two prestigious lectureships: the 2026 Jimmie C. Holland Lecture (Fall 2026 Meeting) and the 2027 Charles G. Moertel Lecture (Spring 2027 Meeting): 1. The 2026 Jimmie C. Holland Lecturer About the Award: Jimmie C. Holland, MD, founded the field of psycho-oncology, a discipline…
Help the Alliance Illustrate Clinical Trials – SUBMIT YOUR SITE PHOTOS The Alliance for Clinical Trials in Oncology needs your help as it prepares to launch a fresh visual identity across its digital platforms. To capture the heart of cancer research and care, we are asking our member institutions to share original, high-quality photographs that…
PRO-TECT trial shows remote symptom monitoring reduces health disparities and emergency visits while improving quality of life in underserved populations New results from an Alliance Foundation Trials (AFT) study reveal that a simple weekly electronic symptom check-in with care team, significantly improves the quality of life for individuals undergoing treatment for advanced cancer. The study…
At the Alliance for Clinical Trials in Oncology, our media relations efforts are designed to alert the public about the vital work happening across our network. When we share stories about groundbreaking clinical trials, scientific milestones, or investigator achievements, we are showcasing the real-world progress you help make possible. These media features serve a crucial…
The Alliance for Clinical Trials in Oncology is currently seeking nominations for two prestigious lectureships: the 2026 Jimmie C. Holland Lecture (Fall 2026 Meeting) and the 2027 Charles G. Moertel Lecture (Spring 2027 Meeting): 1. The 2026 Jimmie C. Holland Lecturer About the Award: Jimmie C. Holland, MD, founded the field of psycho-oncology, a discipline…
The Alliance for Clinical Trials in Oncology has launched a new national study to see if an immune-boosting drug can help keep early-stage lung cancer from coming back after surgery. Alliance A082302 aims to enroll 336 participants in this phase III trial specifically focusing on patients with stage I non-small cell lung cancer. Currently, after…
Today, Alliance Foundation Trials, LLC (AFT) was informed that the U.S. Food and Drug Administration has approved palbociclib in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for adult patients with hormone receptor–positive (HR+), human epidermal growth factor receptor 2–positive (HER2+) locally advanced or metastatic breast cancer following induction treatment. This marks a…